Trevi Therapeutics (TRVI) Free Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.04% |
| Dec 31, 2025 | 29.94% |
| Sep 30, 2025 | -7.83% |
| Jun 30, 2025 | 25.05% |
| Mar 31, 2025 | -41.02% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -10.05% |
| Jun 30, 2024 | 17.04% |
| Mar 31, 2024 | -64.03% |
| Dec 31, 2023 | 12.55% |
| Sep 30, 2023 | 26.40% |
| Jun 30, 2023 | -20.12% |
| Mar 31, 2023 | -28.03% |
| Dec 31, 2022 | 24.83% |
| Sep 30, 2022 | -38.86% |
| Jun 30, 2022 | 12.92% |
| Mar 31, 2022 | -13.85% |
| Dec 31, 2021 | 13.98% |
| Sep 30, 2021 | 8.32% |
| Jun 30, 2021 | -4.22% |
| Mar 31, 2021 | 15.13% |
| Dec 31, 2020 | -27.89% |
| Sep 30, 2020 | 17.24% |
| Jun 30, 2020 | -80.53% |
| Mar 31, 2020 | 24.65% |
| Dec 31, 2019 | 19.81% |
| Sep 30, 2019 | -52.82% |
| Jun 30, 2019 | -23.29% |
| Mar 31, 2019 | 14.90% |
| Dec 31, 2018 | -20.84% |
| Sep 30, 2018 | 28.97% |
| Jun 30, 2018 | -40.11% |